Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/20/2003US6565851 Relieving symptoms of erectile dysfunction with proanthocyanidins
05/20/2003US6565850 Hemorrhoidal compositions and method of use
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565845 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains
05/20/2003US6565832 Spray composition with reduced dripping
05/20/2003US6565829 Psychological disorders; central nervous system disorders
05/20/2003CA2363469A1 Diagnosis of the parkinsonian condition
05/20/2003CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
05/20/2003CA2281244C Process for preparing trovafloxacin acid salts
05/20/2003CA2234239C Indole carbamates as leukotriene antagonists
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/20/2003CA2132429C Alkylthio alkyl avermectins are active antiparasitic agents
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/20/2003CA2099994C Phenyl amidines derivatives useful as platelet aggregation inhibitors
05/20/2003CA2088254C Treatment for hypercholesterolemia
05/20/2003CA2070524C Retinoids substituted by a dithiane cyclic and their use, process for the preparation of these compounds, cosmetic and pharmaceutical compositions containing them and therapeutical use of said compositions
05/20/2003CA2046014C Reduction or prevention of skin irritation by drugs
05/19/2003CA2363528A1 Immediate release tablet containing naproxen sodium
05/16/2003CA2363376A1 Solid pharmaceutical compositions for oral administration comprising itraconazole
05/15/2003WO2003041128A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003WO2003040691A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003WO2003040399A2 Therapeutic methods for nucleic acid delivery vehicles
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040368A2 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040351A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040339A2 Antisense modulation of purinoreceptor p2x¿3?
05/15/2003WO2003040337A2 Polyamide modulators of cox2 transcription
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040294A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
05/15/2003WO2003040184A1 Novel protein and dna thereof
05/15/2003WO2003040174A2 Substituted amino ketone compounds
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040148A1 A process for the preparation of cefixime via alkyl-or aryl-sulfonates
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040145A1 Anhydrous crystal form of valaciclovir hydrochloride
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040143A1 Amine salts of an integrin receptor antagonist
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040140A1 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
05/15/2003WO2003040138A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040137A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040136A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040135A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040131A1 Aminopyrimidines and pyridines
05/15/2003WO2003040128A1 Pyridine derivatives as nmda receptor ligands
05/15/2003WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003WO2003040126A1 φ-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040122A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
05/15/2003WO2003040121A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003WO2003040119A1 Angiogenesis inhibitors
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040114A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/15/2003WO2003040113A1 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
05/15/2003WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
05/15/2003WO2003040109A2 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040105A1 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
05/15/2003WO2003040102A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
05/15/2003WO2003040101A1 Anthranilic acid amides and pharmaceutical use thereof
05/15/2003WO2003040099A1 Preparation of benzosuberonylpiperidine compounds
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040097A1 Nitrogenous compounds, production process, and method of use thereof
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003040077A1 Combretastatin a-4 derivatives having antineoplastic activity
05/15/2003WO2003039677A2 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
05/15/2003WO2003039616A1 Percutaneous transluminal drug delivery device
05/15/2003WO2003039612A1 Intraluminal device with a coating containing a therapeutic agent
05/15/2003WO2003039599A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
05/15/2003WO2003039598A1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain
05/15/2003WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
05/15/2003WO2003039596A1 Photodynamic therapy for the treatment of hair loss
05/15/2003WO2003039583A1 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions
05/15/2003WO2003039582A1 Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
05/15/2003WO2003039581A1 Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
05/15/2003WO2003039578A1 Treatment of congestive heart failure
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039573A1 TARGETING THE REVERSE MODE OF THE Na+/Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY
05/15/2003WO2003039572A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003WO2003039571A1 Improved use of antitumoral compound in cancer therapy
05/15/2003WO2003039569A1 Process for the preparation of anthocyanin-containaing products
05/15/2003WO2003039568A1 Anticancer compositions
05/15/2003WO2003039567A1 Anticancer compositions
05/15/2003WO2003039563A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003WO2003039561A1 Pharmaceutical composition
05/15/2003WO2003039560A1 Antitumor agent containing lactic acid oligomer mixture
05/15/2003WO2003039559A1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
05/15/2003WO2003039557A1 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
1 ... 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 ... 7860